ACADIA Pharmaceuticals (ACAD)
(Delayed Data from NSDQ)
$15.21 USD
-1.92 (-11.21%)
Updated May 9, 2024 04:00 PM ET
After-Market: $15.19 -0.02 (-0.13%) 6:28 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Earnings News For ACAD
-
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
-
Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
-
Acadia: Q1 Earnings Snapshot
-
Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview
-
Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?
-
Why Is Acadia (ACAD) Down 23.4% Since Last Earnings Report?
-
Acadia (ACAD) Q4 Earnings Lag, Sales Beat Estimates, Stock Down
-
Acadia: Q4 Earnings Snapshot
-
Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates
-
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview
-
Acadia Pharmaceuticals (ACAD) Earnings Expected to Grow: Should You Buy?
-
Acadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock Up
-
Acadia: Q3 Earnings Snapshot
-
Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview
-
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
-
Acadia (ACAD) Down 0.7% Since Last Earnings Report: Can It Rebound?
-
Acadia (ACAD) Q2 Earnings & Revenues Beat Estimates, '23 View Up
-
Acadia Pharmaceuticals (ACAD) Q2 Earnings and Revenues Beat Estimates
-
Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overview
-
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Acadia (ACAD) Up 12% Since Last Earnings Report: Can It Continue?
-
Acadia Pharmaceuticals (ACAD) Q1 Earnings & Sales Miss Estimates
-
Acadia Pharmaceuticals (ACAD) Reports Q1 Loss, Lags Revenue Estimates
-
Acadia: Q1 Earnings Snapshot
-
Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results and Operating Overview